The Valley Desk

Clinical trial reportHead & neckPublished

Safety and Efficacy Findings From a Phase Ib/II Study of ASP-1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Thomas Jefferson University. Affiliation source

Publication record

Type
Clinical trial report
Venue
Head & neck
Published
Subject terms
Humans; Head and Neck Neoplasms; Neoplasm Recurrence, Local; Treatment Outcome; Immunotherapy; Phototherapy; Adult; Aged; Middle Aged; Female; Male; Antibodies, Monoclonal, Humanized
PubMed ID
40852760
PubMed Central ID
PMC12703558
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal